Friday - September 25, 2026
AstraZeneca: Alexion Advances Pioneering Leadership in GMG Care With Data at 2026 AANEM Annual Meeting and MGFA Scientific Session
September 25, 2026
WILMINGTON, Delaware, Sept. 25 -- AstraZeneca, a biopharmaceutical company, issued the following news release:

* * *

Alexion advances pioneering leadership in gMG care with data at 2026 AANEM Annual Meeting and MGFA Scientific Session

24 September 2026

New long-term data will further substantiate potential of gefurulimab as once-weekly subcutaneous self-administered treatment for adults with gMG

Additional data will showcase commit . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products